Zobrazeno 1 - 10
of 10
pro vyhledávání: '"María Eugenia G Naranjo"'
Autor:
Carolina Céspedes-Garro, Gerardo Jiménez-Arce, María-Eugenia G. Naranjo, Ramiro Barrantes, Adrián LLerena
Publikováno v:
Revista de Biología Tropical, Vol 62, Iss 4, Pp 1659-1671 (2014)
CYP2D6 differences have already been demonstrated within Latin American populations by the CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics (RIBEF, as per the acronym in Spanish). However, within the population of Costa Rica, no
Externí odkaz:
https://doaj.org/article/9044287b5f054dc5b5f84a2c8d623cca
Autor:
Pedro Dorado, Idilio González, Adrián LLerena, Fernando de Andrés, Luis R Calzadilla, Eva M Peñas-Lledó, María Eugenia G Naranjo
Publikováno v:
OMICS: A Journal of Integrative Biology. 21:17-26
A long-standing question and dilemma in precision medicine is whether and to what extent genotyping or phenotyping drug metabolizing enzymes such as CYP2D6 can be used in real-life global clinical and societal settings. Although in an ideal world usi
Autor:
María-Eugenia G. Naranjo, Fernanda Rodrigues-Soares, Eva M. Peñas-Lledó, Eduardo Tarazona-Santos, Humberto Fariñas, Idania Rodeiro, Enrique Terán, Manuela Grazina, Graciela E. Moya, Marisol López-López, Alba P. Sarmiento, Luis R. Calzadilla, Ronald Ramírez-Roa, Rocío Ortiz-López, Francisco E. Estévez-Carrizo, Martha Sosa-Macías, Ramiro Barrantes, Adrián LLerena, Verónica Fcrreiro, Marilia O. Scliar, Mateus H Gouveia, Angélica Borbón, Gerardo Jiménez-Arce, Carolina Céspedes-Garro, Mayra Álvárez, René Delgado, Diadelis Remirez, Bárbaro Pérez, Francisco Hernández, Santiago Terán, Augusto Rojas-Martinez, Lourdes Garza-Ocañas, Yadira X. Pérez-Páramo, Alberto Ortega-Vázquez, Nancy Monroy-Jaramillo, Helgi Jung-Cook, Ingrid Fricke-Galindo, Carlos Galaviz-Hernández, Ismael Lares-Aseff, Blanca P. Lazalde-Ramos, Catalina Altamirano Tinoco, Roxana Zamudio, Robert H. Gilman, Jesús Cobaleda, Fernando de Andrés, Pedro Dorado, Eugenia G. Naranjo
Publikováno v:
OMICS: A Journal of Integrative Biology. 2018, 22(09)
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Repositorio Institucional (UCA)
Pontificia Universidad Católica Argentina
instacron:UCA
Fil: Naranjo, María Eugenia G. RIBEF Ibero-American Network of Pharmacogenetics and Pharmacogenomics; España Fil: Naranjo, María Eugenia G. Universidad de Extremadura; España Fil: Rodrigues Soares, Fernanda. RIBEF Ibero-American Network of Pharma
Autor:
Blanca Patricia Lazalde Ramos, Adrián LLerena, Martha Sosa-Macías, María Eugenia G Naranjo, Fernando de Andrés
Publikováno v:
Omics : a journal of integrative biology. 21(9)
Global precision medicine demands characterization of drug metabolism and phenotype variation in diverse populations, including the indigenous societies. A related question is the extent to which CYP450 drug metabolizing enzyme genotype and phenotype
Autor:
Idalia Garza-Veloz, Blanca Patricia Lazalde-Ramos, Martha Sosa-Macías, María Eugenia G Naranjo, Margarita L Martinez-Fierro, Adrián LLerena, Carlos Galaviz-Hernández
Publikováno v:
Pharmacogenomics. 15:339-348
Aim: Polymorphisms in CYP2D6 impact the interindividual and interethnic variability of drug efficiency; therefore, we determined the CYP2D6 allele distribution in eight Amerindian groups from northwestern Mexico and compared them with the frequencies
Publikováno v:
CYP2D6: Genetics, Pharmacology and Clinical Relevance. :54-66
Publikováno v:
Personalized Medicine. 10:709-718
Aim:CYP2D6 codes for a protein that is vastly involved in the metabolism of various substances. This gene is highly polymorphic, which influences the enzymatic activity and contributes to the huge variability in the enzyme hydroxylation capacity. Dif
Autor:
Eva M Peñas-Lledó, Ingrid Fricke-Galindo, Humberto Fariñas, Marisol López-López, Fernando de Andrés, María Eugenia G Naranjo, Carolina Céspedes-Garro, Fernanda Rodrigues-Soares, Adrián LLerena
Publikováno v:
Expert opinion on drug metabolismtoxicology. 11(12)
Notably differences in CYP2C9 allele frequencies among worldwide populations have been reported, with an interesting low frequency of the CYP2C9*2 allele in Amerindians compared with Admixed and European populations.Literature was searched using the
Autor:
Eva M Peñas-Lledó, Humberto Fariñas, Adrián LLerena, Fernanda Rodrigues-Soares, María Eugenia G Naranjo, Eduardo Tarazona-Santos
Publikováno v:
Expert opinion on drug metabolismtoxicology. 10(11)
The frequency of CYP2D6 alleles, related to either a lack of or increased enzymatic activity, which may lead to poor metabolism (PM) or ultrarapid metabolism (UM), can vary across ethnic groups and hence across geographic regions.Worldwide original r
Autor:
Pedro Dorado, Eva M Peñas-Lledó, María Eugenia G Naranjo, Alfredo de la Rubia, Idilio González, Adrián LLerena, Antonio P. González, Fernando de Andrés
Publikováno v:
Drug Metabolism and Drug Interactions. 27
Background Aripiprazole (ARI) is an antipsychotic drug that is metabolized to dehydroaripiprazole (DARI) by CYP2D6. Because of the large interindividual variability in ARI and DARI plasma concentrations, therapeutic drug monitoring may be of use in p